Coordinate stabilization of growth-regulatory transcripts in T cell malignancies

Genomics

Volumn 86, Issue 2, 2005, Pages 159-171

  Vlasova, Irina A ^a   McNabb, Jennifer ^a   Raghavan, Arvind ^a,d   Reilly, Cavan ^b   Williams, Darlisha A ^a   Bohjanen, Kimberly A ^c   Bohjanen, Paul R ^a,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Cutaneous T cell lymphoma; Gene expression; Malignancy; Microarray; mRNA decay; mRNA stability; T cell; T cell leukemia; T lymphocyte

Indexed keywords

ARTICLE; CANCER GROWTH; CELL GROWTH; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE; UPREGULATION;

CELL LINE, TUMOR; CELL PROLIFERATION; DACTINOMYCIN; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JURKAT CELLS; LEUKEMIA, T-CELL; MITOCHONDRIA; NUCLEIC ACID SYNTHESIS INHIBITORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; PHENOTYPE; PROTEASOME ENDOPEPTIDASE COMPLEX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; T-LYMPHOCYTES; UBIQUITIN; UP-REGULATION;

EID: 21544481148     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygeno.2005.04.013     Document Type: Article

References (58)

1. A. Raghavan, and P.R. Bohjanen Microarray-based analyses of mRNA decay in the regulation of mammalian gene expression Brief Funct. Genom. Proteom. 3 2004 112 124
2. N.L. Bernasconi, T.A. Wormhoudt, and I.A. Laird-Offringa Post-transcriptional deregulation of myc genes in lung cancer cell lines Am. J. Respir. Cell Mol. Biol. 23 2000 560 565
3. D.F. Aghib A 3′ truncation of MYC caused by chromosomal translocation in a human T-cell leukemia increases mRNA stability Oncogene 5 1990 707 711
4. F. Meijlink, T. Curran, A.D. Miller, and I.M. Verma Removal of a 67-base-pair sequence in the noncoding region of protooncogene fos converts it to a transforming gene Proc. Natl. Acad. Sci. U. S. A. 82 1985 4987 4991
5. V. Raymond, J.A. Atwater, and I.M. Verma Removal of an mRNA destabilizing element correlates with the increased oncogenicity of proto-oncogene fos Oncogene Res. 5 1989 1 12
6. E.A. Raetz, and P.J. Moos Impact of microarray technology in clinical oncology Cancer Invest. 22 2004 312 320
7. J.M. Dodson, P.T. Charles, D.A. Stenger, and J.J. Pancrazio Quantitative assessment of filter-based cDNA microarrays: gene expression profiles of human T-lymphoma cell lines Bioinformatics 18 2002 953 960
8. L.A. Espinoza, and M.E. Smulson Macroarray analysis of the effects of JP-8 jet fuel on gene expression in Jurkat cells Toxicology 189 2003 181 190
9. L.M. Staudt, and P.O. Brown Genomic views of the immune system Annu. Rev. Immunol. 18 2000 829 859
10. M.A. Frevel p38 mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts Mol. Cell. Biol. 23 2003 425 436
11. L.T. Lam Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol Genome Biol. 2 2001 (RESEARCH0041)
12. A. Raghavan Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes Nucleic Acids Res. 30 2002 5529 5538
13. J.M. Tebo Heterogeneity in control of mRNA stability by AU-rich elements J. Biol. Chem. 278 2003 12085 12093
14. E. Yang Decay rates of human mRNAs: correlation with functional characteristics and sequence attributes Genome Res. 13 2003 1863 1872
15. T. Bakheet, B.R. Williams, and K.S. Khabar ARED 2.0: an update of AU-rich element mRNA database Nucleic Acids Res. 31 2003 421 423
16. A. Raghavan Patterns of coordinate down-regulation of ARE-containing transcripts following immune cell activation Genomics 84 2004 1002 1013
17. D.L. Mueller, M.K. Jenkins, and R.H. Schwartz Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy Annu. Rev. Immunol. 7 1989 445 480
18. T. Lindsten, C.H. June, J.A. Ledbetter, G. Stella, and C.B. Thompson Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway Science 244 1989 339 343
19. M. Muratani, and W.P. Tansey How the ubiquitin-proteasome system controls transcription Nat. Rev. Mol. Cell Biol. 4 2003 192 201
20. V. Jesenberger, and S. Jentsch Deadly encounter: ubiquitin meets apoptosis Nat. Rev. Mol. Cell Biol. 3 2002 112 121
21. T.V. Brennan, J.W. Anderson, Z. Jia, E.B. Waygood, and S. Clarke Repair of spontaneously deamidated HPr phosphocarrier protein catalyzed by the l-isoaspartate-(d-aspartate) O-methyltransferase J. Biol. Chem. 269 1994 24586 24595
22. P. Bross, B.S. Andresen, I. Knudsen, T.A. Kruse, and N. Gregersen Human ClpP protease: cDNA sequence, tissue-specific expression and chromosomal assignment of the gene FEBS Lett. 377 1995 249 252
23. K. Izeradjene, L. Douglas, A. Delaney, and J.A. Houghton Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells Clin. Cancer Res. 10 2004 6650 6660
24. D. Michaelson Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding J. Cell Biol. 152 2001 111 126
25. R.A. Britton Isolation and preliminary characterization of the human and mouse homologues of the bacterial cell cycle gene era Genomics 67 2000 78 82
26. K. Nozawa, M. Suzuki, M. Takemura, and S. Yoshida In vitro expansion of mammalian telomere repeats by DNA polymerase alpha-primase Nucleic Acids Res. 28 2000 3117 3124
27. G.C. Ireton, L. Stewart, L.H. Parker, and J.J. Champoux Expression of human topoisomerase I with a partial deletion of the linker region yields monomeric and dimeric enzymes that respond differently to camptothecin J. Biol. Chem. 275 2000 25820 25830
28. T. Shimi Dynamic interaction between BAF and emerin revealed by FRAP, FLIP, and FRET analyses in living HeLa cells J. Struct. Biol. 147 2004 31 41
29. R.T. Richardson Characterization of the histone H1-binding protein, NASP, as a cell cycle-regulated somatic protein J. Biol. Chem. 275 2000 30378 30386
30. C.V. Nicchitta Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity Nat. Rev. Immunol. 3 2003 427 432
31. P. Liang, and A.B. Pardee Analysing differential gene expression in cancer Nat. Rev. Cancer 3 2003 869 876
32. A. Celeste H2AX haploinsufficiency modifies genomic stability and tumor susceptibility Cell 114 2003 371 383
33. J.E. Wibley, T.R. Waters, K. Haushalter, G.L. Verdine, and L.H. Pearl Structure and specificity of the vertebrate anti-mutator uracil-DNA glycosylase SMUG1 Mol. Cell 11 2003 1647 1659
34. K. Lechward, O.S. Awotunde, W. Swiatek, and G. Muszynska Protein phosphatase 2A: variety of forms and diversity of functions Acta Biochim. Pol. 48 2001 921 933
35. A. Strasser, L. O'Connor, and V.M. Dixit Apoptosis signaling Annu. Rev. Biochem. 69 2000 217 245
36. E. Carballo, W.S. Lai, and P.J. Blackshear Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin Science 281 1998 1001 1005
37. C.Y. Chen AU binding proteins recruit the exosome to degrade ARE-containing mRNAs Cell 107 2001 451 464
38. P.R. Bohjanen, B. Petryniak, C.H. June, C.B. Thompson, and T. Lindsten An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3′ untranslated region of lymphokine mRNA Mol. Cell. Biol. 11 1991 3288 3295
39. P.R. Bohjanen, B. Petryniak, C.H. June, C.B. Thompson, and T. Lindsten AU RNA-binding factors differ in their binding specificities and affinities J. Biol. Chem. 267 1992 6302 6309
40. X.C. Fan, and J.A. Steitz Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs EMBO J. 17 1998 3448 3460
41. L.P. Ford, J. Watson, J.D. Keene, and J. Wilusz ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system Genes Dev. 13 1999 188 201
42. A. Raghavan HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities J. Biol. Chem. 276 2001 47958 47965
43. J. Shim, H. Lim, R.Y. J, and M. Karin Nuclear export of NF90 is required for interleukin-2 mRNA stabilization Mol. Cell 10 2002 1331 1344
44. N. Xu, C.Y. Chen, and A.B. Shyu Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover Mol. Cell. Biol. 21 2001 6960 6971
45. J.D. Keene, and S.A. Tenenbaum Eukaryotic mRNPs may represent posttranscriptional operons Mol. Cell 9 2002 1161 1167
46. M. Wada Serum concentration and localization in tumor cells of proteasomes in patients with hematologic malignancy and their pathophysiologic significance J. Lab. Clin. Med. 121 1993 215 223
47. T. Lavabre-Bertrand Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies Cancer 92 2001 2493 2500
48. R. Verma, and R.J. Deshaies A proteasome howdunit: the case of the missing signal Cell 101 2000 341 344
49. A. Ciechanover, D. Shkedy, M. Oren, and B. Bercovich Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin-carrier protein, E2 J. Biol. Chem. 269 1994 9582 9589
50. D. Shkedy, H. Gonen, B. Bercovich, and A. Ciechanover Complete reconstitution of conjugation and subsequent degradation of the tumor suppressor protein p53 by purified components of the ubiquitin proteolytic system FEBS Lett. 348 1994 126 130
51. R. Rajendra Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53 J. Biol. Chem. 279 2004 36440 36444
52. O.M. Sieber, K. Heinimann, and I.P. Tomlinson Genomic instability-The engine of tumorigenesis? Nat. Rev. Cancer 3 2003 701 708
53. Q. Xu, M. Farah, J.M. Webster, and R.J. Wojcikiewicz Bortezomib rapidly suppresses ubiquitin thiolesterification to ubiquitin-conjugating enzymes and inhibits ubiquitination of histones and type I inositol 1,4,5-trisphosphate receptor Mol. Cancer Ther. 3 2004 1263 1269
54. C. Yu, M. Rahmani, P. Dent, and S. Grant The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib Exp. Cell Res. 295 2004 555 566
55. K.A. Frauwirth, and C.B. Thompson Regulation of T lymphocyte metabolism J. Immunol. 172 2004 4661 4665
56. T. LaGrandeur, and R. Parker The cis acting sequences responsible for the differential decay of the unstable MFA2 and stable PGK1 transcripts in yeast include the context of the translational start codon RNA 5 1999 420 433
57. J.S. Jackson Jr., S.S. Houshmandi, F. Lopez Leban, and W.M. Olivas Recruitment of the Puf3 protein to its mRNA target for regulation of mRNA decay in yeast RNA 10 2004 1625 1636
58. A. Raghavan HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities J. Biol. Chem. 276 2001 47958 47965